No Heading
Purpose.
To link the aptness to freeze-drying and the stability under storage to the topology of lipid nanocapsules.
Methods.
The aptness to freeze-drying and the stability under storage of lipid nanocapsules prepared from different compositions with a lecithin content in the 2–20% range were estimated from the preservation of the physical structure, preventing the leakage of the oily phase. The influence of the outer shell composition and of the physical characteristics (investigated by photon correlation spectroscopy and differential scanning calorimetry) on the physical stability was correlated to the topology of the nanoparticulate carrier.
Results.
Confirming the assumption that lecithin confers hardness to the outer shell of lipid nanocap-sules, this study shows that the aptness to freeze-drying and the stability under storage depend on the Solutol®/lecithin (S/L) ratio in the formulation. The DSC study points out a complexation between lecithin and trehalose, the cryoprotectant, reinforcing the stabilising properties of lecithin.
Conclusions.
This paper is a contribution to methodological development of the formulation of lipid nanocapsules, with a special emphasis on the aptness to freeze-drying and the stability under storage.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- DSC:
-
differential scanning calorimetry
- ICH:
-
International Committee of Harmonization
- LNs:
-
lipid nanocapsules
- PEG:
-
polyethylene glycol
- PI:
-
polydispersity index
- RH:
-
relative humidity
- SD:
-
standard deviation
References
1. B. Heurtault, P. Saulnier, J.-P. Benoît, J.-E. Proust, B. Pech, and J. Richard. Lipid Nanocapsules, preparation method and use as a medicine. Patent No. W001/64328 (2000).
2. B. Heurtault, P. Saulnier, B. Pech, J.-P. Benoit, and J.-E. Proust. Interfacial stability of lipid nanocapsules. Colloids Surf. B Biointerfaces 30:225–235 (2003).
3. P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier. Nanocapsule technology: A review. Crit. Rev. Therapeutic Drug Carrier Sys. 19:99–134 (2002).
4. F. Dalençon, Y. Amjaud, C. Lafforgue, F. Derouin, and H. Fessi. Atovaquone and rifabutine-loaded nanocapsules: formulation studies. Int. J. Pharm. 153:127 (1998).
5. B. Hubert, J. Atkinson, M. Guerret, M. Hoffman, J.-P. Devissaguet, and P. Maincent. The preparation and acute antihypertensive effects of a nanoparticular form of darodipine, a dihydropyridine calcium entry blocker. Pharm. Res. 8:734 (1991).
6. G. Barrat, F. Puisieux, W.-P. Yu, C. Foucher, H. Fessi, and J.-P. Devissaguet. Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. Int. J. Immunopharmacol. 16:457 (1994).
7. P. Calvo, M.-J. Alonso, J.-L. Vila-Jato, and J.-R. Robinson. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J. Pharm. Pharmacol. 48:1147 (1996).
8. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust, and J.-P. Benoît. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm. Res. 19:875–880 (2002).
9. T. Förster, F. Schambil, and H. Tesmann. Emulsification by the phase inversion temperature method: The role of self-bodying agents and the influence of oil polarity. Int. J. Cosmet. Sci. 12:217–227 (1990).
10. B. Heurtault, P. Saulnier, B. Pech, J.-E. Proust, and J.-P. Benoît. Properties of polyethylene glycol 660 12 hydroxy stearate at the triglycerides/water interface. Int. J. Pharm. 242:167–170 (2002).
11. B. Heurtault, P. Saulnier, B. Pech, M.-C. Venier-Julienne, J.-E. Proust, R. Phan-Tan-Luu, and J.-P. Benoît. The influence of lipid nanocapsule composition on their size distribution. Eur. J. Pharm. Sci. 18:55–61 (2003).
12. D. J. W. Grant and G. G. Liversidge. Influence of physicochemical interactions on the properties of suppositories. III. Rheological behaviour of fatty suppository bases and its effect on spreading in rats. Drug Dev. Ind. Pharm. 9:247–266 (1983).
13. D. Bazile, C. Ropert, P. Huve, T. Verecchia, M. Marlard, A. Frydman, M. Veillard, and G. Splenlehauer. Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials 13:1093–1102 (1992).
14. J.-P. Benoît and A. Lamprecht. Use of P-glycoprotein inhibitor surfactants at the surface of a colloidal carrier fro inhibiting P-glycoprotein. Patent No. PCT/FR03/00456 (2003).
15. M. Nakagaki, H. Nagase, and H. Ueda. Stabilization of the lamellar structure of phosphatidylcholine by complex formation with trehalose. J. Membr. Sci. 73:173–180 (1992).
16. L. M. Crowe. Lessons from nature: the role of sugars in anhy-drobiosis. Comparative Biochem. Physiol. Part A. 131:505–513 (2002).
17. E. C. van Winden and D. J. Crommelin. Short term stability of freeze-dried, lyoprotected liposomes. J. Control. Rel. 58:69–86 (1999).
18. J. H. Crowe, F. Tablin, W. F. Wolkers, K. Gousset, and N. M. Tsvetkova, and J. Ricker. Stabilization of membranes in human platelets freeze-dried with trehalose. Chem. Phys. Lipids 122:41–52 (2003).
19. W. Q. Sun, A. C. Leopold, L. M. Crowe, and J. H. Crowe. Stability of dry liposomes in sugar glasses. Biophys. J. 70:1769–1776 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dulieu, C., Bazile, D. Influence of Lipid Nanocapsules Composition on Their Aptness to Freeze-Drying. Pharm Res 22, 285–292 (2005). https://doi.org/10.1007/s11095-004-1196-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-004-1196-0